Peer-reviewed veterinary case report
Puppy with lymphangiosarcoma treated successfully with toceranib
By Kim, Ji-Hyun et al.·Published in The Canadian veterinary journal = La revue veterinaire canadienne·2018·Department of Veterinary Surgery (Ji-Hyun Kim, South Korea·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Successful management of lymphangiosarcoma in a puppy using a tyrosine kinase inhibitor.
- Species:
- dog
Plain-English summary
A puppy was diagnosed with lymphangiosarcoma, a type of cancer affecting the lymphatic system, which caused swelling in its legs. The veterinarian started treatment with a medication called toceranib, which is a tyrosine kinase inhibitor. After the treatment, the puppy's symptoms improved, and the lesions went away. Remarkably, the puppy has remained cancer-free for over a year now.
People also search for: puppy lymphangiosarcoma treatment · toceranib for dog cancer · dog leg swelling cancer
Abstract
A puppy was diagnosed with lymphangiosarcoma associated with lymphedema based on lymphography and histopathology. The lesions resolved after toceranib therapy, and the dog remains in remission 1 year later. This is the first report of a successful outcome following oral toceranib as first-line therapy for lymphangiosarcoma in a dog.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/29606721/